Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 26, 2015 1:17 PM ET

Healthcare Equipment and Supplies

Company Overview of Lumenis Ltd.

Company Overview

Lumenis Ltd., together with its subsidiaries, develops and commercializes energy-based medical systems for use in minimally invasive procedures worldwide. It operates through three segments: Surgical, Ophthalmic, and Aesthetic. The Surgical segment offers surgical laser systems and accessories used for urology/genitourinary and ENT to hospitals, outpatient clinics, ambulatory surgery centers, and medical practices. The Ophthalmic segment sells ophthalmology laser systems and accessories, such as laser links, slit lamp microscopes, laser indirect ophthalmoscopes, physician eye safety filters, surgical laser probes, and others to ophthalmic practices, outpatient clinics, and ophthalmology depa...

Yokneam Industrial Park

Hakidma 6

PO Box No. 240

Yokneam,  2069204


Founded in 1991

954 Employees


972 4 959 9000


972 4 959 9050

Key Executives for Lumenis Ltd.

Chief Executive Officer
Age: 50
Chief Financial Officer
Age: 42
Vice President of Global Operations
Age: 49
Senior Vice President and Regional President of China & APAC
Age: 50
Vice President and Regional President of Europe, Middle East & Africa
Compensation as of Fiscal Year 2015.

Lumenis Ltd. Key Developments

Lumenis Ltd.(NasdaqGS:LMNS) dropped from NASDAQ Composite Index

Lumenis Ltd. will be removed from Nasdaq Composite Index.

Lumenis Introduces the New Pulse(TM) 100H and Pulse(TM) 50H Holmium Laser Systems

Lumenis Ltd. announced the launch of Lumenis Pulse(TM) 100H and Lumenis Pulse(TM) 50H at the 33rd World Congress of Endourology (WCE), taking place October 1 - 4, 2015 in London, UK. The Lumenis Pulse 100H, the next generation of the VersaPulse(R) PowerSuite(TM) 100 Watt system, is a versatile and enhanced laser solution for the treatment of a wide array of clinical urologic indications including benign prostatic hyperplasia (BPH), stones, tumors or strictures, along with a range of other specialties such as general surgery, ENT, gynecology and pulmonary surgery. As a greatly effective laser system for stones and BPH, the Pulse 100H enables users to perform holmium laser enucleation of the prostate (HoLEP), the gold standard treatment for BPH, and stone dusting(TM). The new system features an improved design to enhance patient safety and overall user experience. It offers a robust combination of laser parameters addressing more than 70 types of procedures, an innovative pulse reshape function for improved safety, dual pedals for improved ease of use, a hands-free ready and standby mode for minimizing cost per procedure, and a high energy per pulse of up to 3.5J with a high repetition rate of up to 50Hz. In addition to the Pulse 100H, Lumenis will also be unveiling another key addition to the Lumenis Pulse laser family, the Pulse 50H laser system. Designed to efficiently address any type or size of stone in lithotripsy, the Pulse 50H system is a superior comprehensive solution that provides 0.2J of energy per pulse to minimize migration of even the smallest stone. Furthermore, the Pulse 50H can be later upgraded to the new Pulse 100H, allowing physicians to further leverage their investment as they grow their practice.

Lumenis Ltd. Launches New Surgical CO2 Laser Platform for ENT Conditions

Lumenis Ltd. has launched the UltraPulse DUO, a new surgical CO2 laser platform designed to address a wider spectrum of ENT conditions. Featuring superior precision and high-end performance technology, the UltraPulse DUO provides surgeons with the option to easily shift between free beam and fiber energy deliveries all within the same platform. This unique energy delivery combination allows for the superior precision needed to protect delicate tissue and the extended flexibility required for targeting difficult-to-reach anatomy. During oncological procedures, clean and clear margins are valued in pathology and are a key goal in present operating room. The UltraPulse DUO generates clear margin visibility that can lead to better oncological outcomes. Patients undergoing treatment with UltraPulse DUO may benefit from fewer adverse events, such as adhesions and quicker recovery time, because of the system's capability to highly preserve adjacent delicate and healthy tissue. As a true combination of the Digital AcuBlade Scanning Micromanipulator and the FiberLase CO2 laser fiber, the platform provides surgeons with an optimal laser solution with its short learning curve and featuring the market's only system with an adjustable aiming beam and a renewable tip.

Similar Private Companies By Industry

Company Name Region
EZ Orthopedics Limited Middle East/Africa
Circ MedTech Ltd. Middle East/Africa
Pro-Laser Ltd. Middle East/Africa
BlueWind Medical Ltd. Middle East/Africa
Nurami Medical Ltd Middle East/Africa

Recent Private Companies Transactions

November 2, 2015
Pollogen Ltd.
June 18, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Lumenis Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at